IXICO plc is a United Kingdom-based company that provides specialist data analytics services to the global biopharmaceutical industry. The services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. The outputs from the data analysis are used to enhance patient selection, monitor drug safety, and assess clinical efficacy of the drug under development. It offers a range of services, such as drug development analytics, imaging operations, post-marketing, and post-marketing. It offers end to end services, including trial design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway.
Registrars: |
Capita Registrars |
CEO: |
Giulio Cerroni |
Non-Executive Director: |
Kate Rogers |
Non-Executive Chairman: |
Charles Spicer |
Senior Independent Director: |
Mark Warne |
Chief Finance Officer: |
Grant Nash |
Independent Non-Executive Director: |
Dipti Amin |
Address: |
4th Floor, Griffin Court, 15 Long Lane, London. United Kingdom. |
Phone: |
+44 (0)20 3763 7499 |
Fax: |
+44 (0)1480 417090 |
Website: |
http://ixico.com/ |
Email: |
|